Nivolumab plus interferon-γ in the treatment of intractable mucormycosis

Lancet Infect Dis. 2017 Jan;17(1):18. doi: 10.1016/S1473-3099(16)30541-2.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Abdomen / diagnostic imaging
  • Abdomen / microbiology
  • Adjuvants, Immunologic / therapeutic use*
  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Fungemia / diagnostic imaging
  • Fungemia / microbiology
  • Fungemia / therapy*
  • Gastrectomy
  • Humans
  • Immunization
  • Interferon-gamma / therapeutic use*
  • Mucormycosis / diagnostic imaging
  • Mucormycosis / microbiology
  • Mucormycosis / therapy*
  • Nivolumab
  • Spleen / diagnostic imaging
  • Spleen / microbiology
  • Splenectomy
  • Stomach / diagnostic imaging
  • Stomach / microbiology
  • Tomography, X-Ray Computed

Substances

  • Adjuvants, Immunologic
  • Antibodies, Monoclonal
  • Nivolumab
  • Interferon-gamma